Search

everythinglearnresearchcommunity

for

Search:↓

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

ILC1-like cells can cause alopecia areata by themselves.

Botulinum toxin-A reduces wound and skin graft contraction.

Bimekizumab effectively treated a man's chronic beard hair loss.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Overexpressing CtBP1 in skin cells causes skin and hair problems.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Mutations in TBX3 cause horses to have more even hair color instead of Dun camouflage.

BCG injection helps reduce long COVID symptoms and affects hair loss differently in men and women.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

NFIB and STAT5 work together to control specific genetic programs in cells.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Bupropion may help treat trichotillomania when fluoxetine doesn't work.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

Blocking certain brain processes reduces mating behavior in female rats.

Bimatoprost effectively and safely improves eyebrow appearance.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

Thyroxine can adjust the body's peripheral clock, potentially helping treat clock-related diseases.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

Improving oral hygiene and quitting smoking can resolve black hairy tongue.

Scientists discovered a new way UVB light increases skin pigmentation through the ATP-P2X7 pathway.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

TGFBR1 slows down cell growth in fine-wool sheep hair follicles.